Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Quantum Biopharma Ltd. (QNTM) had Return on Equity of -477.10% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-9.25M |
|
-- |
|
-- |
|
$4.85M |
|
$-4.85M |
|
$-4.91M |
|
$-9.77M |
|
$-9.77M |
|
$-9.77M |
|
$-9.77M |
|
$-9.77M |
|
$-9.77M |
|
$-4.85M |
|
$-4.71M |
|
3.02M |
|
3.02M |
|
$-3.23 |
|
$-3.23 |
|
| Balance Sheet Financials | |
$10.34M |
|
$0.07M |
|
$4.95M |
|
$15.30M |
|
$13.25M |
|
-- |
|
-- |
|
$13.25M |
|
$2.05M |
|
$-2.68M |
|
$2.05M |
|
3.47M |
|
| Cash Flow Statement Financials | |
$-6.21M |
|
$-2.71M |
|
$4.42M |
|
$6.00M |
|
$1.50M |
|
$-4.50M |
|
$1.14M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.78 |
|
-- |
|
-- |
|
-- |
|
1.03 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.21M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-477.10% |
364.66% |
|
-63.84% |
|
-477.10% |
|
$0.59 |
|
$-2.06 |
|
$-2.06 |
|